The Global Cardiovascular Digital Solutions Market size is expected to reach $128.1 billion by 2028, rising at a market growth of 4.8% CAGR during the forecast period.
Cardiovascular digital solutions are the fusion and application of digital technologies like software, sensors, wearables,smartphones, artificial intelligence, and virtual healthcare solutions. In order to develop and offer effective healthcare solutions, digital healthcare solutions are being used. The most frequent cause of morbidity andmortality, cardiovascular (CVD) illnesses, necessitates a comprehensive multi-parameter examination beyond the ECG.
For the early detection, monitoring, and treatment of cardiac problems, digital solutions are crucial. This allows for more specialized and effective cardiac care. One of the main reasons propelling the expansion of the cardiovascular digital solutions market is the rise in the prevalence of cardiovascular disorders worldwide, as well as the quickening pace of healthcare technology internationally.
Inadequate or wrong food intake, inactivity, use of tobacco, and excessive alcohol consumption are the biggest behavioral risk factors for cardiovascular diseases like heart disease and stroke. In addition, raised blood pressure, elevated blood glucose, elevated blood lipids, as well as being overweight, and obesity might be symptoms of behavioral risk factors in people. In primary care settings, these 'intermediate risk factors'can be assessed and show a higher risk of complications like heart attack, stroke, and heart failure.
There are other additional underlying causes of CVDs. These reflect the three main forces that are causing social, economic, and cultural change: urbanization, population aging, and globalization. Hereditary factors, stress, and poverty are other CVD predictors. In order to lower cardiovascular risk and stop strokes and heart attacks in persons with these illnesses, the pharmacological treatment for hypertension, diabetes, and excessive blood lipids is also required.
The major strategies followed by the market participants are Product Launches Based on the Analysis presented in the Cardinal matrix; Apple, Inc. and Verily Life Sciences LLC are the forerunners in the Cardiovascular Digital Solutions Market. Companies such as eviCore Healthcare, Koninklijke Philips N.V. and Bardy Diagnostics, Inc., are some of the key innovators in Cardiovascular Digital Solutions Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Apple, Inc., General Electric Company, Koninklijke Philips N.V., Verily Life Sciences LLC (Alphabet, Inc.), iRhythm Technologies, Inc., Bardy Diagnostics, Inc. (Hill-Rom Holdings Inc) (Baxter International Inc.), eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation), AliveCor, Inc., Cardiotrack, and HeartFlow, Inc.
Cardiovascular digital solutions are the fusion and application of digital technologies like software, sensors, wearables,smartphones, artificial intelligence, and virtual healthcare solutions. In order to develop and offer effective healthcare solutions, digital healthcare solutions are being used. The most frequent cause of morbidity andmortality, cardiovascular (CVD) illnesses, necessitates a comprehensive multi-parameter examination beyond the ECG.
For the early detection, monitoring, and treatment of cardiac problems, digital solutions are crucial. This allows for more specialized and effective cardiac care. One of the main reasons propelling the expansion of the cardiovascular digital solutions market is the rise in the prevalence of cardiovascular disorders worldwide, as well as the quickening pace of healthcare technology internationally.
Inadequate or wrong food intake, inactivity, use of tobacco, and excessive alcohol consumption are the biggest behavioral risk factors for cardiovascular diseases like heart disease and stroke. In addition, raised blood pressure, elevated blood glucose, elevated blood lipids, as well as being overweight, and obesity might be symptoms of behavioral risk factors in people. In primary care settings, these 'intermediate risk factors'can be assessed and show a higher risk of complications like heart attack, stroke, and heart failure.
There are other additional underlying causes of CVDs. These reflect the three main forces that are causing social, economic, and cultural change: urbanization, population aging, and globalization. Hereditary factors, stress, and poverty are other CVD predictors. In order to lower cardiovascular risk and stop strokes and heart attacks in persons with these illnesses, the pharmacological treatment for hypertension, diabetes, and excessive blood lipids is also required.
COVID-19 Impact Analysis
Patients with mild symptoms were required to consult online as part of the social distancing procedures. Additionally, it eased the strain on hospitals already overburdened with COVID-19 patient counts. The development ofMedical IoT devices also helpedpatientsmaximize outpatient care and reduce follow-up visits.These devices couldalso be employed in an emergency. Additionally, the resource shortage encountered during the pandemic ledto the development of value-based and competitive pricing models. Therefore, the pandemic had a favorable impact on the market.Market Growth Factors
Rising use of cutting-edge treatment methods
New cardiovascular therapy alternatives are being developed, and the MedTech CVD industry is growing, owing to the adoption of cutting-edge treatment technologies like TAVR and 3D printing. Providers are looking for a wide range of therapeutic, diagnostic, and monitoring solutions that they can use to manage the patient journey. These solutions should be empowered by the right technology, backed by research and a compelling value proposition, and made available at the appropriate time. This will propel the growth of the cardiovascular digital solutions market in the coming years.Shifts in providers and healthcare delivery methods
There is mounting evidence that certain CVD initiatives centered on digital tools have benefited patients and physicians alike. For example, since devices may collect data via remote connectivity, digital health interventions for patients may result in fewer doctor visits. Furthermore, digital solutions can be used as clinical decision-support tools by healthcare professionals who input patient data to produce therapy suggestions. Hence, the changing methods of healthcare delivery and availability of healthcare providers have substantiated the use of technology to cater to more patients in a shorter time, which has also boosted the growth prospects for the market.Market Restraining Factor
Insufficiently qualified staff for clinical trials
According to the Association of Clinical Research Organizations, there is a particularly great need for clinical trial associates (CTA) and clinical research associates (CRA). Unfortunately, over the past ten years, the problem has worsened because neither manufacturers nor CROs has provided graduates with enough skill training to meet the needs of the industry's research. This talent gap may hinder the adoption of innovative techniques and technology, which may have an adverse effect on the market for cardiovascular digital solutions in the years to come.Service Type Outlook
Based on service type, the cardiovascular digital solutions market is categorized into unobtrusive testing, CVD health informatics, cardiac rehab programs, and others. The unobtrusive testing segment garnered the highest revenue share in the cardiovascular digital solutions market in 2021. Unobtrusive monitoring techniques are being deployed to collect physiological signals and characteristics that interfere with a person's daily life, like heart rate, ECG, blood pressure, and blood glucose. In addition, modern advances in inconspicuous and wireless communication technologies enable real-time on-site physiological data collection from remote sites.
Component Outlook
On the basis of components, the cardiovascular digital solutions market is divided into devices and software. The software segment recorded a significant revenue share in the cardiovascular digital solutions market in 2021. An essential marker of a patient's progress in recovering from chronic cardiac diseases is cardiovascular health. Therefore, monitoring cardiovascular health has become an integral part of the therapy strategy, which has increased the demand for software solutions. Cardiologists and clinic staff can easily do cardiac testing with patients using technological breakthroughs and the latest software updates.Deployment Outlook
Based on deployment, the cardiovascular digital solutions market is segmented into cloud-based and on-premises. The cloud-based segment witnessed the maximum revenue share in the cardiovascular digital solutions market in 2021. To stay within budgetary restrictions, the healthcare industry needs to develop efficient ways to enhance its resources and decrease spending. Therefore, the adoption of cloud-based solutions by healthcare organizations and hospitals has increased. Cloud-based solutions have emerged as a substitute for the conventional strategy, in which institutions must buy and own all the technology.End-Use Outlook
On the basis of end-use, the cardiovascular digital solutions market is segmented into hospitals & clinics, ambulatory care centers, and others. The ambulatory care centers segment acquired a substantial revenue share in the cardiovascular digital solutions market in 2021. Various circumstances call for using ambulatory cardiac monitoring services like MCOT (Mobile Cardiac Outpatient Telemetry). As it continually monitors heart activity and provides essential information, it enables real-time diagnosis of clinically severe arrhythmias that may arise in transcatheter aortic valve replacement (TAVR) patients after discharge.Regional Outlook
Based on region, the cardiovascular digital solutions market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific region witnessed a considerable growth rate in the cardiovascular digital solutions market in 2021. The expansion of the regional market is being driven by the rise in the elderly population and the advancement of heart health management systems in Asian nations. However, Asia Pacific presents several difficulties in the prevention and treatment of cardiovascular disease as the region with the biggest density of population and the greatest range of cultures, socioeconomic levels, ethnicities, and healthcare systems.The Cardinal Matrix - Cardiovascular Digital Solutions Market Competition Analysis
The major strategies followed by the market participants are Product Launches Based on the Analysis presented in the Cardinal matrix; Apple, Inc. and Verily Life Sciences LLC are the forerunners in the Cardiovascular Digital Solutions Market. Companies such as eviCore Healthcare, Koninklijke Philips N.V. and Bardy Diagnostics, Inc., are some of the key innovators in Cardiovascular Digital Solutions Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Apple, Inc., General Electric Company, Koninklijke Philips N.V., Verily Life Sciences LLC (Alphabet, Inc.), iRhythm Technologies, Inc., Bardy Diagnostics, Inc. (Hill-Rom Holdings Inc) (Baxter International Inc.), eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation), AliveCor, Inc., Cardiotrack, and HeartFlow, Inc.
Strategies Deployed in Cardiovascular Digital Solutions Market
Partnerships, Collaborations and Agreements:
- Jan-2023: Koninklijke Philips N.V. expanded its partnership with Masimo, a global medical technology company. Under this partnership, Koninklijke Philips N.V. would boost patient monitoring abilities in-home telehealth applications with the Masimo W1™ advanced health tracking watch. Moreover, the W1 would combine with Philips’s enterprise patient monitoring ecosystem to extend the forefront of telehealth and telemonitoring.
- Oct-2022: GE Healthcare came into collaboration with Tribun Health, a pioneer in digital pathology workflow solutions. Under this collaboration, both organizations committed to delivering digital pathology departmental solutions that provide healthcare providers with a more comprehensive idea of patient records. Moreover, GE Healthcare would present a data management solution by combining Tribun’s Health Suite data into GE Healthcare’s solution.
- Sep-2022: AliveCor partnered with Biotronik SE & Co KG, a leading medical device company. Under this partnership, AliveCor would integrate its FDA-cleared ECG technology with BIOTRONIK's implantable devices for cardiac rhythm diagnostics. Moreover, this would further enable a comprehensive picture of the patient's heart health while delivering essential understandings for physicians.
- Mar-2022: GE Healthcare came into partnership with AliveCor, a company that is transforming cardiological care using deep learning. Under this partnership, GE Healthcare's MUSE Cardiac Management System would be integrated with the AliveCor KardiaMobile 6L ECG device. Moreover, medical-grade six-lead electrocardiograms (ECGs) taken by patients on an AliveCor KardiaMobile 6L ECG device outside of the hospital setting would be transferred to GE Healthcare's MUSE Cardiac Management System for physicians to view and evaluate.
- Jan-2018: GE Healthcare came into collaboration with F. Hoffmann-La Roche AG, a Swiss multinational healthcare company that operates worldwide. Under this collaboration, GE Healthcare would co-market and co-develop digital clinical decision-support solutions to enhance therapy for critical care and oncology patients. Moreover, this collaboration would help GE Healthcare to fasten the delivery of data-driven precision health for patients, customers, and the healthcare industry.
Product Launches and Product Expansions:
- Nov-2022: Verily Life Sciences LLC launched Primasun. Primasun is a digital health joint venture between Verily Life Sciences LLC and ResMed Inc.Moreover, Primasun would integrate advanced healthcare research and technology into one complete digital health platform.
- Sep-2022: GE Healthcare unveiled Optima IGS 320. The Optima IGS 320 is a made in India’, ‘AI-powered’ Cath lab product. Additionally, the Cath lab advances the GE proprietary AutoRight technology where AutoRight comes with Artificial Intelligence that automatically optimizes dose and image parameters in real-time allowing clinicians to concentrate their expertise and attention on patients.
- May-2022: AliveCor unveiled the KardiaComplete. The new product KardiaComplete is a complete heart health industry solution created to lower the cost of cardiac care and improved health outcomes. Additionally, this new product would be open for people diagnosed with arrhythmias and hypertension.
- Nov-2021: Koninklijke Philips N.V. unveiled the new AI-enabled innovations in MR imaging. The new MR portfolio of intelligent combined solutions is created to fasten up and streamline workflows, and MR exams, optimize diagnostic quality, and aid secure the sustainability and efficiency of radiology operations.
- Jan-2020: Bardy Diagnostics, Inc. unveiled the Carnation Ambulatory Monitor. The Carnation Ambulatory Monitor is the industry's only P-wave-centric arrhythmia detection device and ambulatory cardiac patch monitor. Additionally, Bardy Diagnostics, Inc. is delighted to create precise and state-of-the-art cardiac monitoring technologies that allow fresh opportunities to redefine and reimagine patient care.
- Aug-2018: Koninklijke Philips N.V. unveiled the EPIQ CVx. The EPIQ CVx is the new cardiovascular ultrasound system developed on a strong EPIQ ultrasound platform. Additionally, EPIQ CVx is specially crafted to improve diagnostic confidence and streamline workflow for clinicians.
Acquisitions and Mergers:
- Jan-2023: GE HealthCare took over IMACTIS, an innovator in the rapidly growing field of computed tomography (CT) interventional guidance across an array of care areas. Through this acquisition, GE Healthcare would be able to strengthen its recommendation offering for customers and patients.
- Nov-2021: Koninklijke Philips N.V. acquired Cardiologs, a France-based medical technology company focused on transforming cardiac diagnostics using artificial intelligence (AI) and cloud technology. Through his acquisition, Koninklijke Philips N.V. would be able to strengthen its diagnostics offering and cardiac monitoring with electrocardiogram (ECG) analysis, creative software technology, and reporting services.
- Feb-2021: Koninklijke Philips N.V. took over Biotelemetry, Inc., a leading U.S.-based provider of remote cardiac diagnostics and monitoring. Through this acquisition, Koninklijke Philips N.V. would be in a favorable position to enhance patient care across care environments for medical conditions and numerous diseases with the help of the combination of both organization's portfolio and service platforms.
Scope of the Study
By Service Type
- Unobtrusive Testing
- CVD Health Informatics
- Cardiac Rehab Programs
- Others
By End-use
- Hospitals & Clinics
- Ambulatory Care Centers
- Others
By Deployment
- Cloud-Based
- On-premise
By Components
- Devices
- Software
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Apple, Inc.
- General Electric Company
- Koninklijke Philips N.V.
- Verily Life Sciences LLC (Alphabet, Inc.)
- iRhythm Technologies, Inc.
- Bardy Diagnostics, Inc. (Hill-Rom Holdings Inc) (Baxter International Inc.)
- eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation)
- AliveCor, Inc.
- Cardiotrack
- HeartFlow, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Cardiovascular Digital Solutions Market, by Service Type
1.4.2 Global Cardiovascular Digital Solutions Market, by End-use
1.4.3 Global Cardiovascular Digital Solutions Market, by Deployment
1.4.4 Global Cardiovascular Digital Solutions Market, by Components
1.4.5 Global Cardiovascular Digital Solutions Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Analyst's Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Aug - 2022, Nov) Leading Players
Chapter 4. Global Cardiovascular Digital Solutions Market by Service Type
4.1 Global Unobtrusive Testing Market by Region
4.2 Global CVD Health Informatics Market by Region
4.3 Global Cardiac Rehab Programs Market by Region
4.4 Global Others Market by Region
Chapter 5. Global Cardiovascular Digital Solutions Market by End-use
5.1 Global Hospitals & Clinics Market by Region
5.2 Global Ambulatory Care Centers Market by Region
5.3 Global Others Market by Region
Chapter 6. Global Cardiovascular Digital Solutions Market by Deployment
6.1 Global Cloud-Based Market by Region
6.2 Global On-premise Market by Region
Chapter 7. Global Cardiovascular Digital Solutions Market by Components
7.1 Global Devices Market by Region
7.2 Global Software Market by Region
Chapter 8. Global Cardiovascular Digital Solutions Market by Region
8.1 North America Cardiovascular Digital Solutions Market
8.1.1 North America Cardiovascular Digital Solutions Market by Service Type
8.1.1.1 North America Unobtrusive Testing Market by Country
8.1.1.2 North America CVD Health Informatics Market by Country
8.1.1.3 North America Cardiac Rehab Programs Market by Country
8.1.1.4 North America Others Market by Country
8.1.2 North America Cardiovascular Digital Solutions Market by End-use
8.1.2.1 North America Hospitals & Clinics Market by Country
8.1.2.2 North America Ambulatory Care Centers Market by Country
8.1.2.3 North America Others Market by Country
8.1.3 North America Cardiovascular Digital Solutions Market by Deployment
8.1.3.1 North America Cloud-Based Market by Country
8.1.3.2 North America On-premise Market by Country
8.1.4 North America Cardiovascular Digital Solutions Market by Components
8.1.4.1 North America Devices Market by Country
8.1.4.2 North America Software Market by Country
8.1.5 North America Cardiovascular Digital Solutions Market by Country
8.1.5.1 US Cardiovascular Digital Solutions Market
8.1.5.1.1 US Cardiovascular Digital Solutions Market by Service Type
8.1.5.1.2 US Cardiovascular Digital Solutions Market by End-use
8.1.5.1.3 US Cardiovascular Digital Solutions Market by Deployment
8.1.5.1.4 US Cardiovascular Digital Solutions Market by Components
8.1.5.2 Canada Cardiovascular Digital Solutions Market
8.1.5.2.1 Canada Cardiovascular Digital Solutions Market by Service Type
8.1.5.2.2 Canada Cardiovascular Digital Solutions Market by End-use
8.1.5.2.3 Canada Cardiovascular Digital Solutions Market by Deployment
8.1.5.2.4 Canada Cardiovascular Digital Solutions Market by Components
8.1.5.3 Mexico Cardiovascular Digital Solutions Market
8.1.5.3.1 Mexico Cardiovascular Digital Solutions Market by Service Type
8.1.5.3.2 Mexico Cardiovascular Digital Solutions Market by End-use
8.1.5.3.3 Mexico Cardiovascular Digital Solutions Market by Deployment
8.1.5.3.4 Mexico Cardiovascular Digital Solutions Market by Components
8.1.5.4 Rest of North America Cardiovascular Digital Solutions Market
8.1.5.4.1 Rest of North America Cardiovascular Digital Solutions Market by Service Type
8.1.5.4.2 Rest of North America Cardiovascular Digital Solutions Market by End-use
8.1.5.4.3 Rest of North America Cardiovascular Digital Solutions Market by Deployment
8.1.5.4.4 Rest of North America Cardiovascular Digital Solutions Market by Components
8.2 Europe Cardiovascular Digital Solutions Market
8.2.1 Europe Cardiovascular Digital Solutions Market by Service Type
8.2.1.1 Europe Unobtrusive Testing Market by Country
8.2.1.2 Europe CVD Health Informatics Market by Country
8.2.1.3 Europe Cardiac Rehab Programs Market by Country
8.2.1.4 Europe Others Market by Country
8.2.2 Europe Cardiovascular Digital Solutions Market by End-use
8.2.2.1 Europe Hospitals & Clinics Market by Country
8.2.2.2 Europe Ambulatory Care Centers Market by Country
8.2.2.3 Europe Others Market by Country
8.2.3 Europe Cardiovascular Digital Solutions Market by Deployment
8.2.3.1 Europe Cloud-Based Market by Country
8.2.3.2 Europe On-premise Market by Country
8.2.4 Europe Cardiovascular Digital Solutions Market by Components
8.2.4.1 Europe Devices Market by Country
8.2.4.2 Europe Software Market by Country
8.2.5 Europe Cardiovascular Digital Solutions Market by Country
8.2.5.1 Germany Cardiovascular Digital Solutions Market
8.2.5.1.1 Germany Cardiovascular Digital Solutions Market by Service Type
8.2.5.1.2 Germany Cardiovascular Digital Solutions Market by End-use
8.2.5.1.3 Germany Cardiovascular Digital Solutions Market by Deployment
8.2.5.1.4 Germany Cardiovascular Digital Solutions Market by Components
8.2.5.2 UK Cardiovascular Digital Solutions Market
8.2.5.2.1 UK Cardiovascular Digital Solutions Market by Service Type
8.2.5.2.2 UK Cardiovascular Digital Solutions Market by End-use
8.2.5.2.3 UK Cardiovascular Digital Solutions Market by Deployment
8.2.5.2.4 UK Cardiovascular Digital Solutions Market by Components
8.2.5.3 France Cardiovascular Digital Solutions Market
8.2.5.3.1 France Cardiovascular Digital Solutions Market by Service Type
8.2.5.3.2 France Cardiovascular Digital Solutions Market by End-use
8.2.5.3.3 France Cardiovascular Digital Solutions Market by Deployment
8.2.5.3.4 France Cardiovascular Digital Solutions Market by Components
8.2.5.4 Russia Cardiovascular Digital Solutions Market
8.2.5.4.1 Russia Cardiovascular Digital Solutions Market by Service Type
8.2.5.4.2 Russia Cardiovascular Digital Solutions Market by End-use
8.2.5.4.3 Russia Cardiovascular Digital Solutions Market by Deployment
8.2.5.4.4 Russia Cardiovascular Digital Solutions Market by Components
8.2.5.5 Spain Cardiovascular Digital Solutions Market
8.2.5.5.1 Spain Cardiovascular Digital Solutions Market by Service Type
8.2.5.5.2 Spain Cardiovascular Digital Solutions Market by End-use
8.2.5.5.3 Spain Cardiovascular Digital Solutions Market by Deployment
8.2.5.5.4 Spain Cardiovascular Digital Solutions Market by Components
8.2.5.6 Italy Cardiovascular Digital Solutions Market
8.2.5.6.1 Italy Cardiovascular Digital Solutions Market by Service Type
8.2.5.6.2 Italy Cardiovascular Digital Solutions Market by End-use
8.2.5.6.3 Italy Cardiovascular Digital Solutions Market by Deployment
8.2.5.6.4 Italy Cardiovascular Digital Solutions Market by Components
8.2.5.7 Rest of Europe Cardiovascular Digital Solutions Market
8.2.5.7.1 Rest of Europe Cardiovascular Digital Solutions Market by Service Type
8.2.5.7.2 Rest of Europe Cardiovascular Digital Solutions Market by End-use
8.2.5.7.3 Rest of Europe Cardiovascular Digital Solutions Market by Deployment
8.2.5.7.4 Rest of Europe Cardiovascular Digital Solutions Market by Components
8.3 Asia Pacific Cardiovascular Digital Solutions Market
8.3.1 Asia Pacific Cardiovascular Digital Solutions Market by Service Type
8.3.1.1 Asia Pacific Unobtrusive Testing Market by Country
8.3.1.2 Asia Pacific CVD Health Informatics Market by Country
8.3.1.3 Asia Pacific Cardiac Rehab Programs Market by Country
8.3.1.4 Asia Pacific Others Market by Country
8.3.2 Asia Pacific Cardiovascular Digital Solutions Market by End-use
8.3.2.1 Asia Pacific Hospitals & Clinics Market by Country
8.3.2.2 Asia Pacific Ambulatory Care Centers Market by Country
8.3.2.3 Asia Pacific Others Market by Country
8.3.3 Asia Pacific Cardiovascular Digital Solutions Market by Deployment
8.3.3.1 Asia Pacific Cloud-Based Market by Country
8.3.3.2 Asia Pacific On-premise Market by Country
8.3.4 Asia Pacific Cardiovascular Digital Solutions Market by Components
8.3.4.1 Asia Pacific Devices Market by Country
8.3.4.2 Asia Pacific Software Market by Country
8.3.5 Asia Pacific Cardiovascular Digital Solutions Market by Country
8.3.5.1 China Cardiovascular Digital Solutions Market
8.3.5.1.1 China Cardiovascular Digital Solutions Market by Service Type
8.3.5.1.2 China Cardiovascular Digital Solutions Market by End-use
8.3.5.1.3 China Cardiovascular Digital Solutions Market by Deployment
8.3.5.1.4 China Cardiovascular Digital Solutions Market by Components
8.3.5.2 Japan Cardiovascular Digital Solutions Market
8.3.5.2.1 Japan Cardiovascular Digital Solutions Market by Service Type
8.3.5.2.2 Japan Cardiovascular Digital Solutions Market by End-use
8.3.5.2.3 Japan Cardiovascular Digital Solutions Market by Deployment
8.3.5.2.4 Japan Cardiovascular Digital Solutions Market by Components
8.3.5.3 India Cardiovascular Digital Solutions Market
8.3.5.3.1 India Cardiovascular Digital Solutions Market by Service Type
8.3.5.3.2 India Cardiovascular Digital Solutions Market by End-use
8.3.5.3.3 India Cardiovascular Digital Solutions Market by Deployment
8.3.5.3.4 India Cardiovascular Digital Solutions Market by Components
8.3.5.4 South Korea Cardiovascular Digital Solutions Market
8.3.5.4.1 South Korea Cardiovascular Digital Solutions Market by Service Type
8.3.5.4.2 South Korea Cardiovascular Digital Solutions Market by End-use
8.3.5.4.3 South Korea Cardiovascular Digital Solutions Market by Deployment
8.3.5.4.4 South Korea Cardiovascular Digital Solutions Market by Components
8.3.5.5 Singapore Cardiovascular Digital Solutions Market
8.3.5.5.1 Singapore Cardiovascular Digital Solutions Market by Service Type
8.3.5.5.2 Singapore Cardiovascular Digital Solutions Market by End-use
8.3.5.5.3 Singapore Cardiovascular Digital Solutions Market by Deployment
8.3.5.5.4 Singapore Cardiovascular Digital Solutions Market by Components
8.3.5.6 Malaysia Cardiovascular Digital Solutions Market
8.3.5.6.1 Malaysia Cardiovascular Digital Solutions Market by Service Type
8.3.5.6.2 Malaysia Cardiovascular Digital Solutions Market by End-use
8.3.5.6.3 Malaysia Cardiovascular Digital Solutions Market by Deployment
8.3.5.6.4 Malaysia Cardiovascular Digital Solutions Market by Components
8.3.5.7 Rest of Asia Pacific Cardiovascular Digital Solutions Market
8.3.5.7.1 Rest of Asia Pacific Cardiovascular Digital Solutions Market by Service Type
8.3.5.7.2 Rest of Asia Pacific Cardiovascular Digital Solutions Market by End-use
8.3.5.7.3 Rest of Asia Pacific Cardiovascular Digital Solutions Market by Deployment
8.3.5.7.4 Rest of Asia Pacific Cardiovascular Digital Solutions Market by Components
8.4 LAMEA Cardiovascular Digital Solutions Market
8.4.1 LAMEA Cardiovascular Digital Solutions Market by Service Type
8.4.1.1 LAMEA Unobtrusive Testing Market by Country
8.4.1.2 LAMEA CVD Health Informatics Market by Country
8.4.1.3 LAMEA Cardiac Rehab Programs Market by Country
8.4.1.4 LAMEA Others Market by Country
8.4.2 LAMEA Cardiovascular Digital Solutions Market by End-use
8.4.2.1 LAMEA Hospitals & Clinics Market by Country
8.4.2.2 LAMEA Ambulatory Care Centers Market by Country
8.4.2.3 LAMEA Others Market by Country
8.4.3 LAMEA Cardiovascular Digital Solutions Market by Deployment
8.4.3.1 LAMEA Cloud-Based Market by Country
8.4.3.2 LAMEA On-premise Market by Country
8.4.4 LAMEA Cardiovascular Digital Solutions Market by Components
8.4.4.1 LAMEA Devices Market by Country
8.4.4.2 LAMEA Software Market by Country
8.4.5 LAMEA Cardiovascular Digital Solutions Market by Country
8.4.5.1 Brazil Cardiovascular Digital Solutions Market
8.4.5.1.1 Brazil Cardiovascular Digital Solutions Market by Service Type
8.4.5.1.2 Brazil Cardiovascular Digital Solutions Market by End-use
8.4.5.1.3 Brazil Cardiovascular Digital Solutions Market by Deployment
8.4.5.1.4 Brazil Cardiovascular Digital Solutions Market by Components
8.4.5.2 Argentina Cardiovascular Digital Solutions Market
8.4.5.2.1 Argentina Cardiovascular Digital Solutions Market by Service Type
8.4.5.2.2 Argentina Cardiovascular Digital Solutions Market by End-use
8.4.5.2.3 Argentina Cardiovascular Digital Solutions Market by Deployment
8.4.5.2.4 Argentina Cardiovascular Digital Solutions Market by Components
8.4.5.3 UAE Cardiovascular Digital Solutions Market
8.4.5.3.1 UAE Cardiovascular Digital Solutions Market by Service Type
8.4.5.3.2 UAE Cardiovascular Digital Solutions Market by End-use
8.4.5.3.3 UAE Cardiovascular Digital Solutions Market by Deployment
8.4.5.3.4 UAE Cardiovascular Digital Solutions Market by Components
8.4.5.4 Saudi Arabia Cardiovascular Digital Solutions Market
8.4.5.4.1 Saudi Arabia Cardiovascular Digital Solutions Market by Service Type
8.4.5.4.2 Saudi Arabia Cardiovascular Digital Solutions Market by End-use
8.4.5.4.3 Saudi Arabia Cardiovascular Digital Solutions Market by Deployment
8.4.5.4.4 Saudi Arabia Cardiovascular Digital Solutions Market by Components
8.4.5.5 South Africa Cardiovascular Digital Solutions Market
8.4.5.5.1 South Africa Cardiovascular Digital Solutions Market by Service Type
8.4.5.5.2 South Africa Cardiovascular Digital Solutions Market by End-use
8.4.5.5.3 South Africa Cardiovascular Digital Solutions Market by Deployment
8.4.5.5.4 South Africa Cardiovascular Digital Solutions Market by Components
8.4.5.6 Nigeria Cardiovascular Digital Solutions Market
8.4.5.6.1 Nigeria Cardiovascular Digital Solutions Market by Service Type
8.4.5.6.2 Nigeria Cardiovascular Digital Solutions Market by End-use
8.4.5.6.3 Nigeria Cardiovascular Digital Solutions Market by Deployment
8.4.5.6.4 Nigeria Cardiovascular Digital Solutions Market by Components
8.4.5.7 Rest of LAMEA Cardiovascular Digital Solutions Market
8.4.5.7.1 Rest of LAMEA Cardiovascular Digital Solutions Market by Service Type
8.4.5.7.2 Rest of LAMEA Cardiovascular Digital Solutions Market by End-use
8.4.5.7.3 Rest of LAMEA Cardiovascular Digital Solutions Market by Deployment
8.4.5.7.4 Rest of LAMEA Cardiovascular Digital Solutions Market by Components
Chapter 9. Company Profiles
9.1 Apple, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 General Electric Company
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.5.3 Acquisition and Mergers:
9.3 Koninklijke Philips N.V.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.3.5.3 Acquisition and Mergers:
9.4 Verily Life Sciences LLC (Alphabet, Inc.)
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.5 iRhythm Technologies, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Research & Development Expense
9.6 Bardy Diagnostics, Inc.(Hill-Rom Holdings Inc)(Baxter International Inc.)
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Product Launches and Product Expansions:
9.7 eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental Analysis
9.8 AliveCor, Inc.
9.8.1 Company Overview
9.8.2 Recent strategies and developments:
9.8.2.1 Partnerships, Collaborations, and Agreements:
9.8.2.2 Product Launches and Product Expansions:
9.9 Cardiotrack
9.9.1 Company Overview
9.10. HeartFlow, Inc.
9.10.1 Company Overview
Companies Mentioned
- Apple, Inc.
- General Electric Company
- Koninklijke Philips N.V.
- Verily Life Sciences LLC (Alphabet, Inc.)
- iRhythm Technologies, Inc.
- Bardy Diagnostics, Inc.(Hill-Rom Holdings Inc)(Baxter International Inc.)
- eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation)
- AliveCor, Inc.
- Cardiotrack
- HeartFlow, Inc.
Methodology
LOADING...
